ID A0A1I5YXH9_9RHOB Unreviewed; 1509 AA.
AC A0A1I5YXH9;
DT 05-DEC-2018, integrated into UniProtKB/TrEMBL.
DT 05-DEC-2018, sequence version 1.
DT 24-JAN-2024, entry version 20.
DE SubName: Full=Natural product biosynthesis luciferase-like monooxygenase domain-containing protein {ECO:0000313|EMBL:SFQ48948.1};
GN ORFNames=SAMN05421853_10728 {ECO:0000313|EMBL:SFQ48948.1};
OS Roseivivax halotolerans.
OC Bacteria; Pseudomonadota; Alphaproteobacteria; Rhodobacterales;
OC Roseobacteraceae; Roseivivax.
OX NCBI_TaxID=93684 {ECO:0000313|EMBL:SFQ48948.1, ECO:0000313|Proteomes:UP000243106};
RN [1] {ECO:0000313|Proteomes:UP000243106}
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=JCM 10271 {ECO:0000313|Proteomes:UP000243106};
RA Varghese N., Submissions S.;
RL Submitted (OCT-2016) to the EMBL/GenBank/DDBJ databases.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; FOXV01000007; SFQ48948.1; -; Genomic_DNA.
DR STRING; 93684.SAMN05421853_10728; -.
DR Proteomes; UP000243106; Unassembled WGS sequence.
DR GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW.
DR GO; GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro.
DR GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR GO; GO:0009058; P:biosynthetic process; IEA:InterPro.
DR CDD; cd08700; FMT_C_OzmH_like; 1.
DR Gene3D; 3.30.300.30; -; 1.
DR Gene3D; 3.40.50.12230; -; 1.
DR Gene3D; 3.40.50.980; -; 2.
DR Gene3D; 1.10.1200.10; ACP-like; 1.
DR Gene3D; 3.20.20.30; Luciferase-like domain; 1.
DR Gene3D; 3.40.50.12780; N-terminal domain of ligase-like; 1.
DR InterPro; IPR036736; ACP-like_sf.
DR InterPro; IPR025110; AMP-bd_C.
DR InterPro; IPR045851; AMP-bd_C_sf.
DR InterPro; IPR020845; AMP-binding_CS.
DR InterPro; IPR000873; AMP-dep_Synth/Lig_com.
DR InterPro; IPR042099; ANL_N_sf.
DR InterPro; IPR024011; Biosynth_lucif-like_mOase_dom.
DR InterPro; IPR005793; Formyl_trans_C.
DR InterPro; IPR002376; Formyl_transf_N.
DR InterPro; IPR036477; Formyl_transf_N_sf.
DR InterPro; IPR011034; Formyl_transferase-like_C_sf.
DR InterPro; IPR011251; Luciferase-like_dom.
DR InterPro; IPR036661; Luciferase-like_sf.
DR InterPro; IPR020806; PKS_PP-bd.
DR InterPro; IPR009081; PP-bd_ACP.
DR NCBIfam; TIGR04020; seco_metab_LLM; 1.
DR PANTHER; PTHR45527:SF1; FATTY ACID SYNTHASE; 1.
DR PANTHER; PTHR45527; NONRIBOSOMAL PEPTIDE SYNTHETASE; 1.
DR Pfam; PF00501; AMP-binding; 2.
DR Pfam; PF13193; AMP-binding_C; 1.
DR Pfam; PF00296; Bac_luciferase; 1.
DR Pfam; PF02911; Formyl_trans_C; 1.
DR Pfam; PF00551; Formyl_trans_N; 1.
DR Pfam; PF00550; PP-binding; 1.
DR SMART; SM00823; PKS_PP; 1.
DR SUPFAM; SSF56801; Acetyl-CoA synthetase-like; 2.
DR SUPFAM; SSF47336; ACP-like; 1.
DR SUPFAM; SSF51679; Bacterial luciferase-like; 1.
DR SUPFAM; SSF50486; FMT C-terminal domain-like; 1.
DR SUPFAM; SSF53328; Formyltransferase; 1.
DR PROSITE; PS00455; AMP_BINDING; 1.
DR PROSITE; PS50075; CARRIER; 1.
PE 4: Predicted;
KW Monooxygenase {ECO:0000313|EMBL:SFQ48948.1};
KW Oxidoreductase {ECO:0000313|EMBL:SFQ48948.1};
KW Phosphopantetheine {ECO:0000256|ARBA:ARBA00022450};
KW Phosphoprotein {ECO:0000256|ARBA:ARBA00022553};
KW Reference proteome {ECO:0000313|Proteomes:UP000243106}.
FT DOMAIN 1391..1467
FT /note="Carrier"
FT /evidence="ECO:0000259|PROSITE:PS50075"
FT REGION 1357..1387
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 1471..1509
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 1492..1509
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 1509 AA; 160694 MW; 6CE2553DE35B9C00 CRC64;
MSFTAILIGN DRLTREAGVK LRAAGHTLTA CVTRDGDVAD WASKEGVRVV APGPGLAERL
EGCAADWLLS VANLDLLPPE ILRLGRKGGV NFHDGPLPAY AGVNAPVWAI LNGETRHGIT
WHMLDEGVDR GDILVARSVE IAPEDTALTL NTKCFAAALD SFDTVISELE AGAQNRAPQT
SDKRSYFGLK DRPAHHGTLD FSQTSAQILR LVRALDHGGY PNPVALPKLW TNGALFAIGQ
AQTAEGRGQP GEVLSVADET ITIATSDGAV RLSGLQRLDG SGELPNAGTV LPEPPEDDLS
DLARGEFHWR RALSGYIPAR LPGFGAPTGE TAQMTVSDIP PHALAALAAR LAPEGRADIA
LVTLESVQRA ASGLALPWMP IAAHVEGPAD AFREQMTAKF NAARNAGPLA RDLGHRLAPA
MSLATPAFAI SEGAGPLPGA LLTLETGATQ RLHYDAGAMT ASMAELLAAR LNQLAEWSGD
MADAPLLSEA ERALTLETWN ATETPLADRT MLDRFEAAAQ EHPERVAVVF EDQSLSYADL
DGLANRIAHL LQGAGAAAGA IVGLHLERGP RLVAAALGVL KAGAAYLPID PAYPAERQAH
YLSDSGAAIV LTESAIARSL PRHAAKEIRL DIEPKLFSVP ATRPDPGPDA EALAYLIYTS
GSTGTPKGVM VEHAQVANFF TGMDAVVPDA GNTWLAVTSL NFDISVLELF YALSRGYKVV
MASENVASGV SSGARRASGM AMSLYYWGND DGTGRDKYRT LLEGAKFADA HGFTAVWTPE
RHFHAFGGPY PNPSVTGAAV AGVTSRIGVR AGSCVAPLHH PARVAEEWAV IDNLTEGRAG
LAIASGWQPD DFVLRPENAP PDNKRAMIES IDQIRRLWRG EAVAFPRADG SLHEVVTQPR
PMSKELPLWI TTAGNPETWK EAGRLGANVL THLLGQSIDE VAEKIALYRQ ARAEAGFDPK
TGEVALMLHT YLAETRDAAR EIAREPMKDY LRSAAGLIKQ YAWAFPAFKK PAGVTNPMQL
DLGALEPDEL EAILDHAFER YFNESGLFGT IEDAEVRVAE VQAIGVSEIA CLIDYGIAPD
TILEGLHPLA EVVSRVTGPD LPAEDDFSVA AQIRRHDATH LQCTPSLMRL MLADDGARAA
LGSLSHVFLG GEALPGPLVA ALGKATDARV TNMYGPTETT IWSACGPASP GDGVVPVGAA
IANTRLYVLD DAMEPQPIGA PGELWIGGAG VARGYWKRAA LTEERFRPDP FHGGRMYRTG
DLVARRADGC LDFLGRADGQ VKLRGMRIEL GEVEARLEAL EGVRQAAAVV RDNRLLAFVT
GDAGDETQMK ATLEARLPAH MVPARIVTLD ELPLTPNKKV DRARLPEPTE PKTTRPAPIP
KDARPVRPAQ AGDAATLAEL GEVWSAVLGV SQIGGSDNFF ALGGHSLLAV ELFRAVRDRF
GVTSFAITDV FRFPTLGGMA GRIGELRGDV PAPAERAAET PASPARNARA EARRAAMARR
RQMRARQDS
//
